Jazz Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.02.17	Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating JZP-110 for Excessive Sleepiness in Parkinson's Disease (PR Newswire)
30.01.17	Research Reports Initiation on Biotech Stocks -- Jazz Pharma, Infinity Pharma, Acorda Therapeutics, and Ultragenyx Pharma (PR Newswire)
19.01.17	Gainers & Losers Of The Day: APRI, LIFE, JAZZ, ETRM, BIOC... (RTTNews)
18.01.17	ADHD Doesn't MEASURE Up, JAZZ Abuzz, NBIX Slips On Failed Study (RTTNews)
17.01.17	Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating Defibrotide for the Potential Prevention of VOD in High Risk Patients (PR Newswire)
17.01.17	Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating Defibrotide for the Potential Prevention of VOD in High Risk Patients (PR Newswire)
07.12.16	Technical Reports on Biotech Equities -- Jazz Pharma, Anthera Pharma, ProNAi Therapeutics, and AveXis (PR Newswire)
29.11.16	FOLD Shrinks, JAZZ On Right Track, NVLS Choked Up, AAAP On Watch, NVRO Sues BSX (RTTNews)
28.11.16	Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Study of JZP-110 Evaluating Excessive Sleepiness in Narcolepsy (PR Newswire)
28.11.16	Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Study of JZP-110 Evaluating Excessive Sleepiness in Narcolepsy (PR Newswire)
04.10.16	DVAX Back In News, Spectral Shock For Investors, MACK Giving Pink Slips (RTTNews)
27.09.16	ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial (RTTNews)
31.05.16	CPXX Investors Laughing All The Way To The Bank... (RTTNews)
31.05.16	Jazz Pharma To Buy Celator For $1.5 Bln - Quick Facts (RTTNews)
31.03.16	Be All EARS, DVAX Gets FDA Date, JAZZ Hits Right Notes, It's A No For OPK (RTTNews)
31.03.16	Jazz Pharma Announces FDA Approval Of Defitelio (RTTNews)
24.02.16	Earnings Reported After The Bell Feb. 23 (RTTNews)
10.11.15	Earnings Reported After The Bell Nov.9 (RTTNews)
01.10.15	CLSN Awaits Data In Q4, INFI Hits A Milestone, JAZZ Gets FDA Date (RTTNews)
07.05.15	Jazz Pharma Reports Q1 Adj. EPS Of $1.99 - Quick Facts (RTTNews)
05.11.14	Jazz Pharmaceuticals Q3 Results Beat View, Lifts 2014 Outlook (RTTNews)
05.11.14	Jazz Pharma Results Top Estimate; Lifts FY Guidance (RTTNews)
06.08.14	Jazz Pharma Q2 Adj. Profit Beats Estimate (RTTNews)
02.07.14	Jazz Pharma To Buy Rights To Defibrotide In Americas From Sigma-Tau (RTTNews)
03.06.14	AQXP Goes Sprinting, ARGS On Watch, BIOC Adds New Product, An Insight On RECAP (RTTNews)
19.05.14	Jazz Pharma Appoints Russell Cox As COO (RTTNews)
09.05.14	Jazz Slips To Loss On Expenses; Stock Down - Update (RTTNews)
08.05.14	Jazz Pharma Posts Q1 Loss On Milestone Payment - Quick Facts (RTTNews)
26.02.14	Jazz Pharmaceuticals Q4 Results Miss Estimates, Guides 2014 EPS In Line (RTTNews)
25.02.14	Jazz Pharma Q4 Profit Down - Quick Facts (RTTNews)
13.01.14	Jazz Pharma Acquires Rights To ADX-N05 - Quick Facts (RTTNews)
20.12.13	Jazz Pharma To Acquire Gentium For About $1 Bln (RTTNews)
19.12.13	Jazz Pharma Enters Into Agreement To Acquire Gentium For $57.00 Per Share (RTTNews)
22.10.13	Jazz Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 5, 2013 (PR Newswire)
22.10.13	Jazz Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 5, 2013 (PR Newswire)
09.08.13	Pharmaceutical Companies Announce Quarterly Financial Results - Research Report on Jazz, Acadia, Arena, Santarus, and Incyte (PR Newswire)
06.08.13	JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS (PR Newswire)
06.08.13	Jazz Pharma Profit Rises - Quick Facts (RTTNews)
06.08.13	JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS (PR Newswire)
23.07.13	Jazz Pharmaceuticals To Report Second Quarter 2013 Financial Results on August 6, 2013 (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	71.72	2.37 %	K V
UBS Group	27.98	1.12 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
Geberit	527.20	0.65 %	K V
Kuehne+Nagel Int	210.60	0.57 %	K V
Holcim	88.76	0.07 %	K V
Nestle	76.08	-0.37 %	K V
CieFinRichemont	121.35	-0.45 %	K V
Sonova Hldg	301.00	-0.99 %	K V
Givaudan	3’831.00	-1.26 %	K V

Nachrichten zu Jazz Pharmaceuticals PLC

Aktien Top/Flop

Meistgelesene Nachrichten